TrialDiabetes, obesity & metabolism2026

Impact of Time of Injection on the Efficacy and Safety of iGlarLixi Versus IDegAsp in Chinese People With Type 2 Diabetes: Exploratory Analysis of the Soli-D Study.

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.